The state registration of a medicinal product, purchased by an individual authorised to procure in the field of healthcare and at the same time registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada and used on the territory of these countries or by the competent authority of the European Union under the centralised procedure and used on the territory of the European Union Member States, shall be carried out with the following peculiarities (without restrictions on the possibility of state registration under the procedure specified in part five of this Article):